110956 ⎘
ssRNA viruses negative-sense; Details; Paramyxoviridae; Morbillivirus, e.g. Measles virus, canine distemper Viruses as such, e.g. new isolates, mutants or their genomic sequences
METHOD OF PRODUCING NEGATIVE-STRAND RNA VIRUS VECTOR AND PRODUCED NEGATIVE-STRAND RNA VIRUS VECTOR
#2DNA MOLECULES PRODUCING CUSTOM DESIGNED REPLICATING AND NON-REPLICATING NEGATIVE STRANDED RNA VIRUSES AND USES THERE OF
#3DNA MOLECULES PRODUCING CUSTOM DESIGNED REPLICATING AND NON-REPLICATING NEGATIVE STRANDED RNA VIRUSES AND USES THERE OF
#4Paramyxovirus vaccine strain for novel coronavirus pneumonia and construction method thereof
#5Modified viruses
#6Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
#7Aseptic purification process for viruses
#8Paramyxoviridae expression system
#9DEGRON FUSION CONSTRUCTS AND METHODS FOR CONTROLLING PROTEIN PRODUCTION
#10Recombinant measles virus expressing zika virus prM and E proteins
#11Modified viruses
#12Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
#13Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy
#14DNA molecules producing custom designed replicating and non-replicating negative stranded RNA viruses and uses there of
#15Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy
#16Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
#17Aseptic purification process for viruses
#18Gene-modified measles virus for tumor treatment use
#19RNA viruses for immunovirotherapy
#20Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
#21Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy
#22Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
#23Oncolytic measles virus
#24Recombinant measles virus expressing chikungunya virus polypeptides and their applications
#25Combined measles-malaria vaccine
#26Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions
#27Feline morbillivirus and uses thereof
#28Oncolytic measles virus
#29Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
#30Combined measles-malaria vaccine
#31CDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, and process for the production of such viruses encoding additional antigenically active proteins
#32Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs
#33cDNA corresponding to the antigenome of nonsegmented negative stranded RNA viruses and process for the production of such viruses
#34Infectious recombinant paramyxovirus from antigenomic cDNA
#35Recombinant measles viruses expressing epitopes of antigens of RNA viruses - use for the preparation of vaccine compositions
#36Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions